What Stocks Are Recession-Proof?
Fears of a recession prevailed in Q2 2025 when the…
Buy
54
BBP Quote, Financials, Valuation and Earnings
Last price:
$54.15
Seasonality move
:
8.82%
Day range:
$53.94 - $54.15
52-week range:
$48.65 - $69.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
8.2K
Avg. volume:
3.4K
1-year change:
-3.29%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- |
|
HEAL
Global X HealthTech ETF
|
-- | -- | -- | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BBP
Virtus LifeSci Biotech Products ETF
|
$54.00 | -- | -- | -- | $0.00 | 0% | -- |
|
HEAL
Global X HealthTech ETF
|
$10.78 | -- | -- | -- | $0.00 | 0% | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
$40.88 | -- | -- | -- | $0.01 | 0.24% | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
$35.98 | -- | -- | -- | $0.03 | 0.07% | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
$27.63 | -- | -- | -- | $1.17 | 4.25% | -- |
|
XBI
SPDR S&P Biotech ETF
|
$77.55 | -- | -- | -- | $0.01 | 0.18% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | 1.267 | -- | -- |
|
HEAL
Global X HealthTech ETF
|
-- | 2.088 | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | 1.681 | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | 1.485 | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | 1.374 | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | 1.543 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- | -- |
|
HEAL
Global X HealthTech ETF
|
-- | -- | -- | -- | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
Virtus LifeSci Biotech Products ETF vs. Competitors
-
Which has Higher Returns BBP or HEAL?
Global X HealthTech ETF has a net margin of -- compared to Virtus LifeSci Biotech Products ETF's net margin of --. Virtus LifeSci Biotech Products ETF's return on equity of -- beat Global X HealthTech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BBPVirtus LifeSci Biotech Products ETF-- -- -- HEALGlobal X HealthTech ETF-- -- -- -
What do Analysts Say About BBP or HEAL?
Virtus LifeSci Biotech Products ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X HealthTech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Virtus LifeSci Biotech Products ETF has higher upside potential than Global X HealthTech ETF, analysts believe Virtus LifeSci Biotech Products ETF is more attractive than Global X HealthTech ETF.
Company Buy Ratings Hold Ratings Sell Ratings BBPVirtus LifeSci Biotech Products ETF0 0 0 HEALGlobal X HealthTech ETF0 0 0 -
Is BBP or HEAL More Risky?
Virtus LifeSci Biotech Products ETF has a beta of 0.610, which suggesting that the stock is 38.994% less volatile than S&P 500. In comparison Global X HealthTech ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BBP or HEAL?
Virtus LifeSci Biotech Products ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Global X HealthTech ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Virtus LifeSci Biotech Products ETF pays -- of its earnings as a dividend. Global X HealthTech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BBP or HEAL?
Virtus LifeSci Biotech Products ETF quarterly revenues are --, which are smaller than Global X HealthTech ETF quarterly revenues of --. Virtus LifeSci Biotech Products ETF's net income of -- is lower than Global X HealthTech ETF's net income of --. Notably, Virtus LifeSci Biotech Products ETF's price-to-earnings ratio is -- while Global X HealthTech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Virtus LifeSci Biotech Products ETF is -- versus -- for Global X HealthTech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BBPVirtus LifeSci Biotech Products ETF-- -- -- -- HEALGlobal X HealthTech ETF-- -- -- --
-
Which has Higher Returns BBP or PSCH?
Invesco S&P SmallCap Health Care ETF has a net margin of -- compared to Virtus LifeSci Biotech Products ETF's net margin of --. Virtus LifeSci Biotech Products ETF's return on equity of -- beat Invesco S&P SmallCap Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BBPVirtus LifeSci Biotech Products ETF-- -- -- PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -
What do Analysts Say About BBP or PSCH?
Virtus LifeSci Biotech Products ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P SmallCap Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Virtus LifeSci Biotech Products ETF has higher upside potential than Invesco S&P SmallCap Health Care ETF, analysts believe Virtus LifeSci Biotech Products ETF is more attractive than Invesco S&P SmallCap Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings BBPVirtus LifeSci Biotech Products ETF0 0 0 PSCHInvesco S&P SmallCap Health Care ETF0 0 0 -
Is BBP or PSCH More Risky?
Virtus LifeSci Biotech Products ETF has a beta of 0.610, which suggesting that the stock is 38.994% less volatile than S&P 500. In comparison Invesco S&P SmallCap Health Care ETF has a beta of 0.993, suggesting its less volatile than the S&P 500 by 0.736%.
-
Which is a Better Dividend Stock BBP or PSCH?
Virtus LifeSci Biotech Products ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Invesco S&P SmallCap Health Care ETF offers a yield of 0.24% to investors and pays a quarterly dividend of $0.01 per share. Virtus LifeSci Biotech Products ETF pays -- of its earnings as a dividend. Invesco S&P SmallCap Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BBP or PSCH?
Virtus LifeSci Biotech Products ETF quarterly revenues are --, which are smaller than Invesco S&P SmallCap Health Care ETF quarterly revenues of --. Virtus LifeSci Biotech Products ETF's net income of -- is lower than Invesco S&P SmallCap Health Care ETF's net income of --. Notably, Virtus LifeSci Biotech Products ETF's price-to-earnings ratio is -- while Invesco S&P SmallCap Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Virtus LifeSci Biotech Products ETF is -- versus -- for Invesco S&P SmallCap Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BBPVirtus LifeSci Biotech Products ETF-- -- -- -- PSCHInvesco S&P SmallCap Health Care ETF-- -- -- --
-
Which has Higher Returns BBP or PTH?
Invesco Dorsey Wright Healthcare Momentum ETF has a net margin of -- compared to Virtus LifeSci Biotech Products ETF's net margin of --. Virtus LifeSci Biotech Products ETF's return on equity of -- beat Invesco Dorsey Wright Healthcare Momentum ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BBPVirtus LifeSci Biotech Products ETF-- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- -
What do Analysts Say About BBP or PTH?
Virtus LifeSci Biotech Products ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Dorsey Wright Healthcare Momentum ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Virtus LifeSci Biotech Products ETF has higher upside potential than Invesco Dorsey Wright Healthcare Momentum ETF, analysts believe Virtus LifeSci Biotech Products ETF is more attractive than Invesco Dorsey Wright Healthcare Momentum ETF.
Company Buy Ratings Hold Ratings Sell Ratings BBPVirtus LifeSci Biotech Products ETF0 0 0 PTHInvesco Dorsey Wright Healthcare Momentum ETF0 0 0 -
Is BBP or PTH More Risky?
Virtus LifeSci Biotech Products ETF has a beta of 0.610, which suggesting that the stock is 38.994% less volatile than S&P 500. In comparison Invesco Dorsey Wright Healthcare Momentum ETF has a beta of 0.925, suggesting its less volatile than the S&P 500 by 7.464%.
-
Which is a Better Dividend Stock BBP or PTH?
Virtus LifeSci Biotech Products ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Invesco Dorsey Wright Healthcare Momentum ETF offers a yield of 0.07% to investors and pays a quarterly dividend of $0.03 per share. Virtus LifeSci Biotech Products ETF pays -- of its earnings as a dividend. Invesco Dorsey Wright Healthcare Momentum ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BBP or PTH?
Virtus LifeSci Biotech Products ETF quarterly revenues are --, which are smaller than Invesco Dorsey Wright Healthcare Momentum ETF quarterly revenues of --. Virtus LifeSci Biotech Products ETF's net income of -- is lower than Invesco Dorsey Wright Healthcare Momentum ETF's net income of --. Notably, Virtus LifeSci Biotech Products ETF's price-to-earnings ratio is -- while Invesco Dorsey Wright Healthcare Momentum ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Virtus LifeSci Biotech Products ETF is -- versus -- for Invesco Dorsey Wright Healthcare Momentum ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BBPVirtus LifeSci Biotech Products ETF-- -- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- --
-
Which has Higher Returns BBP or SBIO?
ALPS Medical Breakthroughs ETF has a net margin of -- compared to Virtus LifeSci Biotech Products ETF's net margin of --. Virtus LifeSci Biotech Products ETF's return on equity of -- beat ALPS Medical Breakthroughs ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BBPVirtus LifeSci Biotech Products ETF-- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- -
What do Analysts Say About BBP or SBIO?
Virtus LifeSci Biotech Products ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ALPS Medical Breakthroughs ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Virtus LifeSci Biotech Products ETF has higher upside potential than ALPS Medical Breakthroughs ETF, analysts believe Virtus LifeSci Biotech Products ETF is more attractive than ALPS Medical Breakthroughs ETF.
Company Buy Ratings Hold Ratings Sell Ratings BBPVirtus LifeSci Biotech Products ETF0 0 0 SBIOALPS Medical Breakthroughs ETF0 0 0 -
Is BBP or SBIO More Risky?
Virtus LifeSci Biotech Products ETF has a beta of 0.610, which suggesting that the stock is 38.994% less volatile than S&P 500. In comparison ALPS Medical Breakthroughs ETF has a beta of 0.811, suggesting its less volatile than the S&P 500 by 18.871%.
-
Which is a Better Dividend Stock BBP or SBIO?
Virtus LifeSci Biotech Products ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ALPS Medical Breakthroughs ETF offers a yield of 4.25% to investors and pays a quarterly dividend of $1.17 per share. Virtus LifeSci Biotech Products ETF pays -- of its earnings as a dividend. ALPS Medical Breakthroughs ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BBP or SBIO?
Virtus LifeSci Biotech Products ETF quarterly revenues are --, which are smaller than ALPS Medical Breakthroughs ETF quarterly revenues of --. Virtus LifeSci Biotech Products ETF's net income of -- is lower than ALPS Medical Breakthroughs ETF's net income of --. Notably, Virtus LifeSci Biotech Products ETF's price-to-earnings ratio is -- while ALPS Medical Breakthroughs ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Virtus LifeSci Biotech Products ETF is -- versus -- for ALPS Medical Breakthroughs ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BBPVirtus LifeSci Biotech Products ETF-- -- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- --
-
Which has Higher Returns BBP or XBI?
SPDR S&P Biotech ETF has a net margin of -- compared to Virtus LifeSci Biotech Products ETF's net margin of --. Virtus LifeSci Biotech Products ETF's return on equity of -- beat SPDR S&P Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BBPVirtus LifeSci Biotech Products ETF-- -- -- XBISPDR S&P Biotech ETF-- -- -- -
What do Analysts Say About BBP or XBI?
Virtus LifeSci Biotech Products ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Virtus LifeSci Biotech Products ETF has higher upside potential than SPDR S&P Biotech ETF, analysts believe Virtus LifeSci Biotech Products ETF is more attractive than SPDR S&P Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings BBPVirtus LifeSci Biotech Products ETF0 0 0 XBISPDR S&P Biotech ETF0 0 0 -
Is BBP or XBI More Risky?
Virtus LifeSci Biotech Products ETF has a beta of 0.610, which suggesting that the stock is 38.994% less volatile than S&P 500. In comparison SPDR S&P Biotech ETF has a beta of 0.976, suggesting its less volatile than the S&P 500 by 2.396%.
-
Which is a Better Dividend Stock BBP or XBI?
Virtus LifeSci Biotech Products ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SPDR S&P Biotech ETF offers a yield of 0.18% to investors and pays a quarterly dividend of $0.01 per share. Virtus LifeSci Biotech Products ETF pays -- of its earnings as a dividend. SPDR S&P Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BBP or XBI?
Virtus LifeSci Biotech Products ETF quarterly revenues are --, which are smaller than SPDR S&P Biotech ETF quarterly revenues of --. Virtus LifeSci Biotech Products ETF's net income of -- is lower than SPDR S&P Biotech ETF's net income of --. Notably, Virtus LifeSci Biotech Products ETF's price-to-earnings ratio is -- while SPDR S&P Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Virtus LifeSci Biotech Products ETF is -- versus -- for SPDR S&P Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BBPVirtus LifeSci Biotech Products ETF-- -- -- -- XBISPDR S&P Biotech ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Which Stocks Are Recession-Proof?
Fears of a recession prevailed in Q2 2025 when the…
Is Gartner a Safe Stock to Own?
Gartner (NYSE:IT) is among the world’s largest consulting, research and…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 38x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
70
Is NVDA Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 44x
Alerts
Buy
57
RGC alert for May 14
Regencell Bioscience Holdings [RGC] is up 24.99% over the past day.
Buy
54
HALO alert for May 14
Halozyme Therapeutics [HALO] is down 4.06% over the past day.
Buy
91
COIN alert for May 14
Coinbase Global [COIN] is up 0.82% over the past day.
